Citations

Showing 10 of 108162 citations.

Association of kinesin with the Golgi apparatus in rat hepatocytes
Marks, David L. , Larkin, Janet M., McNiven, Mark A.

Mayo Clinic

Journal of Cell Science | April 25, 2021 | Volume: 107 | Issue: 9 | Pages: 2417-2426

10.1242/jcs.107.9.2417 | PMID 7844161 Get It

ABSTRACT The Golgi apparatus is a dynamic membranous structure, which has been observed to alter its location and morphology during the cell cycle and after microtubule disruption. These dynamics are believed to be supported by a close structural interaction of the Golgi with the microtubule cytoskeleton and associated motor enzymes. One micro-tubule-dependent motor enzyme, kinesin, has been implicated in Golgi movement and function although direct evidence supporting this interaction is lacking. In this study, we utilized two well-characterized kinesin antibodies in conjunction with subcellular fractionation techniques, immunoblot analysis and immunofluorescence microscopy to conduct a detailed study on the association of kinesin with the Golgi and other membranous organelles in a polarized epithelial cell, the primary rat hepatocyte. We found that kinesin represents ∼0.3% of total protein in rat liver homogenates, with ∼30% membrane-associated and the remainder in the cytosol. Among membrane fractions, kinesin was concentrated markedly in Golgi-enriched fractions, which were prepared using two independent techniques. Kinesin was also abundant in fractions enriched in transcytotic carriers and secretory vesicles, with lower levels detected on fractions enriched in endosomes, endoplasmic reticulum, lysosomes and mito-chondria. Immunofluorescence microscopy showed that kinesin is concentrated on Golgi-like structures in both primary cultured hepatocytes and rat hepatocyte-derived clone 9 cells. Double-label immunofluorescence demonstrated that kinesin staining colocalizes with the Golgi marker, α-mannosidase II, in both cell types. These results provide compelling evidence showing that kinesin is associated with the Golgi complex in cells and implicate this motor enzyme in Golgi structure, function and dynamics.
The pericentriolar lattice of PtK2 cells exhibits temperature and calcium modulated behavior
Nemeth, Edward F. , Salisbury, Jeffrey L., Baron, Andre T. , Suman, Vera J.

Mayo Clinic

Journal of Cell Science | April 25, 2021 | Volume: 107 | Issue: 11 | Pages: 2993-3003

10.1242/jcs.107.11.2993 | PMID 7698999 Get It

ABSTRACT In this study, we demonstrate that manipulations of temperature and free calcium alter the morphology of the centrin-containing pericentriolar lattice of PtK2 cells. Immunofluorescence microscopy reveals that low-temperature incubation (4°C) causes anti-centrin-labeled pericentrosomal spots to coalesce in the peripheral cytoplasm, and fuses small spots into larger spots near the cell center. At electron microscopic resolution, well-formed pericentriolar satellites appear around the centrioles in response to incubation at 4°C. Elevated free calcium enhances these low-temperature-dependent effects. The data suggest that peri-centrosomal spots correspond to one or more pericentriolar satellites, and that pericentriolar satellites and centrosomal matrix are interconvertable forms of the same material. Transient elevation of intracellular free calcium at 37°C from a basal level of 3.7×10−8 M to a peak level of 2.0×10−7 M within 30 seconds with ionomycin results in a 35% increase in pericentrosomal spot number throughout the cytoplasm. The number of pericentrosomal spots is 50% larger 2 minutes after ionomycin addition; these spots are also nearer to the cell center as compared to 30 seconds after ionomycin addition. As intracellular free calcium returns to a basal level over 5 minutes, the number of spots and their cellular distribution resume a pretreatment value and pattern. We interpret these observations to indicate movement of pericentrosomal spots toward the cell center in response to the flux in intracellular free calcium. Alternatively, it is possible that no movement has occurred, but that the rise in free calcium has unmasked an epitope responsive to our anti-centrin antiserum. Regardless of the interpretation, we conclude that the pericentriolar lattice exhibits calcium-modulated behavior.
Cloning of a cdna encoding human centrin, an ef-hand protein of centrosomes and mitotic spindle poles
Errabolu, Ramesh, Sanders, Mark A , Salisbury, Jeffrey L.

Mayo Clinic

Journal of Cell Science | April 25, 2021 | Volume: 107 | Issue: 1 | Pages: 9-16

10.1242/jcs.107.1.9 | PMID 8175926 Get It

ABSTRACT A human cDNA expression library was screened using anti-centrin antibodies to obtain a cDNA clone encoding human centrin. The cDNA clone contains an open reading frame of 516 base pairs and predicts a product of 172 amino acids with a calculated molecular mass of 19,528 and a pI of 4.61. Sequence analysis demonstrates that human centrin and centrins from higher plants, protozoa, algae, Xenopus and the yeast CDC31 gene product are closely related members of a subfamily of the EF-hand superfamily of calcium-binding proteins. The human centrin sequence has four putative calcium-binding domains as defined by the EF-hand consensus. Immunoprecipitation and western blot studies from HeLa cells confirm that human centrin is a protein of ∼20,000 Mr as predicted from the cDNA clone. Indirect immunofluorescence analysis of HeLa cells demonstrates that centrin is localized at the cen-trosome of interphase cells and that it redistributes to the region of the spindle poles during mitosis. When taken together with earlier genetic studies, these results demon-strate that centrin is a ubiquitous component of centro-somes and mitotic spindle poles of diverse organisms and suggest that centrin plays a role in centrosome separation at the time of mitosis.
Molecular classification improves risk assessment in adult BCR-ABL1– negative B-ALL
Paietta, Elisabeth , Wang, Victoria , Gu, Zhaohui , Buck, Georgina , Pei, Deqing, Levine, Ross L. , Cheng, Zhongshan , Pounds, Stanley , Racevskis, Janis, Bařinka, Jan , Zhang, Yanming , Dewald, Gordon W., Alejos, David , Luger, Selina M. , Foroni, Letizia, Patel, Bela , Melnick, Ari , Marks, David I. , Moorman, Anthony V. , Wiernik, Peter H. , Rowe, Jacob M. , Tallman, Martin S. , Goldstone, Anthony H., Litzow, Mark R. , Gu, Zhaohui , Harvey, Richard , Lazarus, Hillard M , Fielding, Adele K , Melnick, Ari , Mullighan, Charles G , Litzow, Mark R. , Pounds, Stanley B , Roberts, Kathryn G. , Cheng, Cheng , Abdel‐Wahab, Omar , Wu, Gang , Qu, Chunxu , Shi, Lei Gang , Willman, Cheryl L. , Harvey, Richard C. , Ketterling, Rhett P. , Lazarus, Hillard M. , Fielding, Adele K. , Mullighan, Charles G.

Mayo Clinic

Blood | April 25, 2021 | Volume: 138 | Issue: 11 | Pages: 948-958

10.1182/blood.2020010144 | PMID 33895809 Get It

Abstract Genomic classification has improved risk assignment of pediatric, but not adult B-lineage acute lymphoblastic leukemia (B-ALL). The international UKALLXII/ECOG-ACRIN E2993 (#NCT00002514) trial accrued 1229 adolescent/adult patients with BCR-ABL1− B-ALL (aged 14 to 65 years). Although 93% of patients achieved remission, 41% relapsed at a median of 13 months (range, 28 days to 12 years). Five-year overall survival (OS) was 42% (95% confidence interval, 39, 44). Transcriptome sequencing, gene expression profiling, cytogenetics, and fusion polymerase chain reaction enabled genomic subtyping of 282 patient samples, of which 264 were eligible for trial, accounting for 64.5% of E2993 patients. Among patients with outcome data, 29.5% with favorable outcomes (5-year OS 65% to 80%) were deemed standard risk (DUX4-rearranged [9.2%], ETV6-RUNX1/-like [2.3%], TCF3-PBX1 [6.9%], PAX5 P80R [4.1%], high-hyperdiploid [6.9%]); 50.2% had high-risk genotypes with 5-year OS of 0% to 27% (Ph-like [21.2%], KMT2A-AFF1 [12%], low-hypodiploid/near-haploid [14.3%], BCL2/MYC-rearranged [2.8%]); 20.3% had intermediate-risk genotypes with 5-year OS of 33% to 45% (PAX5alt [12.4%], ZNF384/-like [5.1%], MEF2D-rearranged [2.8%]). IKZF1 alterations occurred in 86% of Ph-like, and TP53 mutations in patients who were low-hypodiploid (54%) and BCL2/MYC-rearranged (33%) but were not independently associated with outcome. Of patients considered high risk based on presenting age and white blood cell count, 40% harbored subtype-defining genetic alterations associated with standard- or intermediate-risk outcomes. We identified distinct immunophenotypic features for DUX4-rearranged, PAX5 P80R, ZNF384-R/-like, and Ph-like genotypes. These data in a large adult B-ALL cohort treated with a non–risk-adapted approach on a single trial show the prognostic importance of genomic analyses, which may translate into future therapeutic benefits.
Ras-independent oncogenic transformation by an EGF-receptor mutant
Boerner, Julie L. , McManus, Michael J., Maihle, Nita J. , Martin, G. Steven

Mayo Clinic

Journal of Cell Science | April 25, 2021 | Volume: 113 | Issue: 6 | Pages: 935-942

10.1242/jcs.113.6.935 | PMID 10683142 Get It

ABSTRACT Mutations in the ligand-binding domain of the epidermal growth factor receptor have been identified in several types of human cancers, including malignant gliomas. These mutations render signaling by this receptor to be constitutively ligand-independent. In fibroblasts transformed with ligand-independent epidermal growth factor receptor mutants, there is a correlation between the formation of a unique phosphotyrosine protein complex and oncogenic transformation. This phosphoprotein complex includes Grb2, Shc, Sos, tyrosine-phosphorylated form of caldesmon, and two, as yet, unidentified proteins. The presence of Grb2, Shc, and Sos in this complex implicates Ras in ligand-independent signaling by these oncogenic epidermal growth factor receptor mutants. We, therefore, have used retroviral co-infections of cultured primary fibroblasts to determine if Ras activation is required for phosphoprotein complex formation, stress fiber loss, or transformation. As predicted, expression of a dominant-negative Ras mutant (N17Ras) completely abrogates ligand-stimulated soft agar colony growth of primary fibroblasts. In contrast, N17Ras expression has no effect on v-ErbB mediated stress fiber disassembly, soft agar colony growth, or phosphoprotein complex assembly. In addition, our data suggest that ligand-dependent Ras activation may be suppressed by oncogenic v-ErbB expression. Together these observations suggest that oncogenic signaling by v-ErbB does not require Ras activation, and implicate an alternative signal transduction pathway in ligand-independent epidermal growth factor receptor oncogenic signaling.
Most of centrin in animal cells is not centrosome-associated and centrosomal centrin is confined to the distal lumen of centrioles
Moudjou, Mohammed , Paintrand, Michel, Salisbury, Jeffrey L., Bornens, Michel , Paoletti, Anne

Mayo Clinic

Journal of Cell Science | April 25, 2021 | Volume: 109 | Issue: 13 | Pages: 3089-3102

10.1242/jcs.109.13.3089 | PMID 9004043 Get It

ABSTRACT Centrin is a member of the calcium-binding EF-hand protein superfamily present in centrosomes of widely divergent species. Investigating the cellular distribution of human centrin by both immunofluorescence and cell fractionation, we report that centrin is biochemically complex in human cells, displaying as much as ten isoforms in 2-D electrophoresis. This suggests that centrin may be subject to multiple regulations. Strikingly, more than 90% of centrin is not associated with the centrosome fraction. The centrosome-associated centrin, however, displays a specific pattern in 2-D electrophoresis and is concentrated within the distal lumen of the centrioles, where a complex structure has been previously described. This precise localization allows the resolution of centrioles at the optical level throughout the cell cycle and provides a valuable tool for monitoring centriole duplication. To get insights on centrin function, we performed injection experiments of recombinant heterologous centrin in two-cell stage frog embryos in an attempt to produce dominant negative effects. We report that green algae and human centrin delay cleavage and promote the formation of abnormal blastomeres in which the distribution of microtubule asters and of nuclei is dramatically impaired. This suggests that centrin could be involved in the centrosome reproduction cycle, in the coordination of cytoplasmic and nuclear division or in cytokinesis.
Use of an adeno‐associated virus serotype Anc80 to provide durable cure of phenylketonuria in a mouse model
Kaiser, Robert A. , Weber, Nicholas D. , Trigueros‐Motos, Laia , Allen, Kari L. , Martinez, Michael , Cao, William, VanLith, Caitlin J. , Hillin, Lori G., Douar, Anne , González‐Aseguinolaza, Gloria , Aldabe, Rafael , Lillegard, Joseph B.

Mayo Clinic

Journal of Inherited Metabolic Disease | April 25, 2021 | Volume: 44 | Issue: 6 | Pages: 1369-1381

10.1002/jimd.12392 | PMID 33896013 Get It

AbstractPhenylketonuria (PKU) is the most common inborn error of metabolism of the liver, and results from mutations of both alleles of the phenylalanine hydroxylase gene (PAH). As such, it is a suitable target for gene therapy via gene delivery with a recombinant adeno‐associated virus (AAV) vector. Here we use the synthetic AAV vector Anc80 via systemic administration to deliver a functional copy of a codon‐optimized human PAH gene, with or without an intron spacer, to the Pahenu2 mouse model of PKU. Dose‐dependent transduction of the liver and expression of PAH mRNA were present with both vectors, resulting in significant and durable reduction of circulating phenylalanine, reaching near control levels in males. Coat color of treated Pahenu2 mice reflected an increase in pigmentation from brown to the black color of control animals, further indicating functional restoration of phenylalanine metabolism and its byproduct melanin. There were no adverse effects associated with administration of AAV up to 5 × 1012 VG/kg, the highest dose tested. Only minor and/or transient variations in some liver enzymes were observed in some of the AAV‐dosed animals which were not associated with pathology findings in the liver. Finally, there was no impact on cell turnover or apoptosis as evaluated by Ki‐67 and TUNEL staining, further supporting the safety of this approach. This study demonstrates the therapeutic potential of AAV Anc80 to safely and durably cure PKU in a mouse model, supporting development for clinical consideration.
Optimising the booking horizon in healthcare clinics considering no-shows and cancellations
Leeftink, Gréanne , Hans, Erwin W. , Sır, Mustafa Y. , Martinez, Gabriela , Pasupathy, Kalyan S.

Mayo Clinic

International Journal of Production Research | April 25, 2021 | Volume: 60 | Issue: 10 | Pages: 3201-3218

10.1080/00207543.2021.1913292 Get It

Antidepressants and Risk of Sudden Cardiac Death: A Network Meta-Analysis and Systematic Review
Cheungpasitporn, Wisit , Tokavanich, Nithi , Ding, Kimberly R., Kaewput, Wisit , Chokesuwattanaskul, Ronpichai , Cheungpasitporn, Wisit , Ding, Kimberly R , Kaewput, Wisit , Chokesuwattanaskul, Ronpichai , Prasitlumkum, Narut , Kewcharoen, Jakrin , Thongprayoon, Charat , Vallabhajosyula, Saraschandra

Mayo Clinic

Medical Sciences | April 25, 2021 | Volume: 9 | Issue: 2 | Pages: 26

10.3390/medsci9020026 | PMID 33922524 Get It

Background: Antidepressants are one of the most prescribed medications, particularly for patients with mental disorders. Nevertheless, there are still limited data regarding the risk of ventricular arrhythmia (VA) and sudden cardiac death (SCD) associated with these medications. Thus, we performed systemic review and meta-analysis to characterize the risks of VA and SCD among patients who used common antidepressants. Methods: A literature search for studies that reported risk of ventricular arrhythmias and sudden cardiac death in antidepressant use from MEDLINE, EMBASE, and Cochrane Database from inception through September 2020. A random-effects model network meta-analysis model was used to analyze the relation between antidepressants and VA/SCD. Surface Under Cumulative Ranking Curve (SUCRA) was used to rank the treatment for each outcome. Results: The mean study sample size was 355,158 subjects. Tricyclic antidepressant (TCA) patients were the least likely to develop ventricular arrhythmia events/sudden cardiac deaths at OR 0.24, 0.028–1.2, OR 0.32 (95% CI 0.038–1.6) for serotonin and norepinephrine reuptake inhibitors (SNRI), and OR 0.36 (95% CI 0.043, 1.8) for selective serotonin reuptake inhibitors (SSRI), respectively. According to SUCRA analysis, TCA was on a higher rank compared to SNRI and SSRI considering the risk of VA/SCD. Conclusion: Our network meta-analysis demonstrated the low risk of VA/SCD among patients using antidepressants for SNRI, SSRI and especially, TCA. Despite the relatively lowest VA/SCD in TCA, drug efficacy and other adverse effects should be taken into account in patients with mental disorders.
A Novel Approach to Improve Newborn Screening for Congenital Hypothyroidism by Integrating Covariate-Adjusted Results of Different Tests into CLIR Customized Interpretive Tools
Rowe, Alexander D. , Stoway, Stephanie D., Åhlman, Henrik, Arora, Vaneet, Caggana, Michele, Fornari, Anna, Hagar, Arthur F. , Marquardt, Gregg, Miller, Bobby J., Nixon, Christopher, Norgan, Andrew P. , Orsini, Joseph J. , Pettersen, Rolf D. , Piazza, Amy L. , Schubauer, Neil R., Smith, Amy C., Tang, Hao , Wei, Sainan , Zetterström, Rolf , Currier, Robert J. , Mørkrid, Lars , Rinaldo, Piero, Hagar, Arthur , Marquardt, Gregg C, Zetterström, Rolf H , Currier, Robert , Norgan, Andrew P , Hall, Patricia , Tavakoli, Norma P.

Mayo Clinic

International Journal of Neonatal Screening | April 25, 2021 | Volume: 7 | Issue: 2 | Pages: 23

10.3390/ijns7020023 | PMID 33922835 Get It

Newborn screening for congenital hypothyroidism remains challenging decades after broad implementation worldwide. Testing protocols are not uniform in terms of targets (TSH and/or T4) and protocols (parallel vs. sequential testing; one or two specimen collection times), and specificity (with or without collection of a second specimen) is overall poor. The purpose of this retrospective study is to investigate the potential impact of multivariate pattern recognition software (CLIR) to improve the post-analytical interpretation of screening results. Seven programs contributed reference data (N = 1,970,536) and two sets of true (TP, N = 1369 combined) and false (FP, N = 15,201) positive cases for validation and verification purposes, respectively. Data were adjusted for age at collection, birth weight, and location using polynomial regression models of the fifth degree to create three-dimensional regression surfaces. Customized Single Condition Tools and Dual Scatter Plots were created using CLIR to optimize the differential diagnosis between TP and FP cases in the validation set. Verification testing correctly identified 446/454 (98%) of the TP cases, and could have prevented 1931/5447 (35%) of the FP cases, with variable impact among locations (range 4% to 50%). CLIR tools either as made here or preferably standardized to the recommended uniform screening panel could improve performance of newborn screening for congenital hypothyroidism.